Wegovy is a brand name for semaglutide, a medication approved for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity
Step 3: Input Your Data and Review the Result Enter your health details into the calculator
A patient-based forecast of sales for Qsymia in obesity anticipates year-on-year increases in sales to the end of the forecast period (2031), when annual US sales are expected to reach $58M
However, persistent redness lasting more than 24 hours, severe swelling, or signs of infection like warmth, pus, or red streaking require medical attention
Distribution channels include hospitals, retail pharmacies, and increasingly, online pharmacies, ensuring wide accessibility